In the Asia Pacific region, demographic trends and changing lifestyle habits will drive rapid IC procedure volume growth as the CAD patient population expands. Although the IC device market will be limited by substantial price cuts in the Indian coronary stent market, falling ASPs, and slow adoption of premium-priced devices, it will experience overall expansion through 2026. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Asia Pacific across a 10-year period.


An expanding and untreated CAD patient population supports growing procedure volumes in the Asia Pacific region.

Which country will experience the strongest growth in procedure volumes?

Which segment of the IC device market will see the greatest increase in procedure volumes through 2026?

Which is the most preferred access point for IC procedures among Asia Pacific physicians?

The DES segment continues to dominate the Asia Pacific market for coronary stents.

What are the prospects for BMS going forward? Will BMS become obsolete during the forecast period?

What are physicians' opinions about BVS, and how do they compare with those surrounding current-generation DES

What impact will recent events in the BVS space have on DES usage patterns?

How are DES technologies likely to evolve over the coming years?

How will the price cap in India affect the Indian coronary stent market going forward?

The Asia Pacific IC device market is characterized by the presence of several domestic manufacturers.

What companies lead the different IC device segments?

In which segments are domestic manufacturers challenging the positions of the international manufacturers, and how?

What strategies are used by international competitors to succeed in this market?

What is the role of distributors in the success of international companies?

What strategies can new competitors employ to gain entry into the Asia Pacific coronary stent market?

Table of contents

  • Asia Pacific
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Interventional Cardiology Device Market
      • Market Highlights
        • Australia
        • China
        • India
        • South Korea
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Local Marketing Strategies
        • Distribution and Sales Network
        • Domestic Competitors
        • Clinical Data
        • Pricing Strategies
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
        • Physician Training and Marketing
      • Market Developments
    • Coronary Stent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • PTCA Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Domestic Competitors
    • Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Domestic Competitors
        • Product Improvements and Innovations
    • Intravascular Imaging Catheter and Pressure Guidewire Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Pricing Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Megha Maheshwari, MBA

Megha Maheshwari is a principal analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional cardiology, aortic repair, and coronary artery bypass graft device markets. In addition to a postgraduate diploma in Hospital Administration with a Certificate in International Medical Tourism and an Associate's degree in Nutrition and Child Care, Megha holds a Bachelor's degree in Physiotherapy from Hemwati Nandan Bahuguna Garhwal University and an MBA in Healthcare IT from NIMS University.


Related Reports

Interventional Cardiology Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European IC device market will continue to grow through 2027, driven largely by expanding procedure volumes—spurred by innovations that a...

View Details

Interventional Cardiology Devices | Medtech 360 | Market Insights | Eastern Europe

Through 2027, the Eastern European market for IC devices will expand modestly, with the expanding

View Details

Interventional Cardiology Devices | Medtech 360 | Market Insights | Europe Part 2

The mature European IC device market will grow slightly through 2027, driven largely by continuing increases in procedure volumes, dri...

View Details

Interventional Cardiology Devices | Medtech 360 | Market Insights | Europe

A highly cost-conscious health care landscape in Europe has placed substantial downward pressure on the large yet contracting European I...

View Details